Furthermore, we observed that breast cancer metastases at any site that harbor mutations in KEAP1, KRAS, and STK11, a triplet commonly associated with lung cancer, genomically resemble lung tumors (100% vs. 18%, p = 2e-8, n = 13). This evidence concerns the gene KRAS and breast carcinoma.